DURLAMDA

DEAD

Serial Number

86055409

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

Filing Date

Sep 4, 2013

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

DURLAMDA Trademark

Serial Number: 86055409

DURLAMDA is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on September 4, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,799 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Legal Representation

Attorney of Record

Marilyn F. Kelly

2,551 trademarks filed View all →

Trademark Details

Filing Date

September 4, 2013

Registration Date

Not Registered

Published for Opposition

April 15, 2014

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Jul 17, 2017 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jul 17, 2017 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 10, 2017 EXRA

SOU EXTENSION 5 GRANTED

Jan 7, 2017 EX5G

SOU EXTENSION 5 FILED

Dec 12, 2016 EXT5

SOU TEAS EXTENSION RECEIVED

Dec 12, 2016 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 21, 2016 EXRA

SOU EXTENSION 4 GRANTED

Jul 20, 2016 EX4G

SOU EXTENSION 4 FILED

Jun 10, 2016 EXT4

SOU TEAS EXTENSION RECEIVED

Jun 10, 2016 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 2, 2016 EXRA

SOU EXTENSION 3 GRANTED

Jan 30, 2016 EX3G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 28, 2016 AITU

SOU EXTENSION 3 FILED

Dec 10, 2015 EXT3

SOU TEAS EXTENSION RECEIVED

Dec 10, 2015 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 11, 2015 EXRA

SOU EXTENSION 2 GRANTED

Jul 10, 2015 EX2G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jul 10, 2015 AITU

SOU EXTENSION 2 FILED

Jun 10, 2015 EXT2

SOU TEAS EXTENSION RECEIVED

Jun 10, 2015 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 13, 2014 EXRA

SOU EXTENSION 1 GRANTED

Dec 10, 2014 EX1G

SOU EXTENSION 1 FILED

Dec 10, 2014 EXT1

SOU TEAS EXTENSION RECEIVED

Dec 10, 2014 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 10, 2014 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 15, 2014 NPUB

PUBLISHED FOR OPPOSITION

Apr 15, 2014 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 26, 2014 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 13, 2014 PREV

ASSIGNED TO LIE

Mar 10, 2014 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 22, 2014 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 21, 2014 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 21, 2014 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 21, 2014 TROA

NOTIFICATION OF PRIORITY ACTION E-MAILED

Dec 17, 2013 GPRN

PRIORITY ACTION E-MAILED

Dec 17, 2013 GPRA

PRIORITY ACTION WRITTEN

Dec 17, 2013 CPRA

ASSIGNED TO EXAMINER

Dec 10, 2013 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 12, 2013 NWOS

NEW APPLICATION ENTERED

Sep 7, 2013 NWAP

Related Trademarks

More from this Owner

EMPLICITI

More in Same Class

NPS PHARMA

IBGARD

WHOLE LIFE

TRIDESILON

SOLTRIENTS